U.S. Citizens Who Contracted Ebola Given Experimental Treatment Developed in San Diego
An experimental serum to treat Ebola that was developed at a laboratory in San Diego has been given to two U.S. citizens who contracted the virus while in Africa. The treatment, known as ZMapp, is being developed by Mapp Biopharmaceutical.
- "Two Americans Who Contracted Ebola in Africa Received an Experimental Serum" (Dennis/Bernstein, Washington Post, 8/4).
- "U.S. Government Had Role in Ebola Drug Given Aid Workers" (AP/Modern Healthcare, 8/4).
This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.